x

Sign In
Shop
Brand
Custom Granule
Custom Raw Herb/ Vaccum Pack
MY ACCOUNT
Patient
Practitioner
Shipping Options & Returns
Herb Guide

Back
Shop

Back
Brand

Back
Symptoms

LOG IN / REGISTER

Please Sign In or Register to access all E-Script Features

Product Details

ERROR

SUCCESS

CONFIRM

Yes No

Vinpurazine (90 Capsules) (Health C...

Customize Rx Label

Reference Name (For your records)*

Formula Label Name (To be printed on label)

Pharmacy Instructions

dosing instruction

Manufacturer Label Unit Size

90 Capsules

Manufacturer Label Dosages

1 or 4 Capsules daily on an empty stomach. It is best to begin with 1/2 - 1 Capsules a day for the first week and then increase if necessary.

Capsule (0.7g)

Times Daily

# of Days

Custom Instructions (60 charecters max)

(Clear this field to disable Custom Instruction)

New prices adjusted to include labelling service fees:

Patient : 0.00

Retainer : 0.00 (Applied in checkout)

Practitioner : 0.00

# of Refills

Save Cancel

Therapeutic Actions 1.Improves cerebral circulation 2.May improve memory 3.Protects nerve cells 4.Post stroke/seizure recovery 5.Myasthenia gravis 6.Experimental treatment for Alzheimer's diseaseFormulaIt is estimated over 100,000 people have been treated with Huperzine A in China where it is used as a treatment for Alzheimer's disease (AD), as well as other kinds of dementia. In addition to being less toxic than current drugs used to treat AD, it appears more effective in a number of areas. Huperzine A is a compound that can be manufactured in the lab or extracted from club moss extract (Huperzia serrata; Qian Ceng Ta), which has been traditionally used to treat fever and inflammation. Research carried out at the Shanghai Institute of Materia Medica found that Huperzine A improved memory significantly better than tacrine or the drug E2020 (Neuroreport 1996, Dec 20: 9(1): 97-101).Fifty patients with (AD) were administered 200 mcg Huperzine A BID for 8 weeks. Twenty-nine out of fifty patients showed improvements in memory, cognitive, and behavioral functions on the basis of the Wechseler memory scale, Hasegawa dementia scale, and other internationally accepted standards. (Chung Kuo Yao Li hsueh pai 1995, Sept; 16 (5) 391-395).Huperzine A may reduce injury to cells from strokes, epilepsy, and other disorders. It is being clinically used for treatment of myasthenia gravis in China. It is also being studied in Israel for its ability to be used prophylactically against nerve gas poisoning.Vinpocetine is derived from the periwinkle plant. It has been used for more than 20 years as a treatment of cerebrovascular disorders. Laboratory experiments indicate that it dilates blood vessels, improves circulation to the brain, improves oxygen utilization, increases glucose metabolism in the brain, and inhibits platelet aggregation. Vinpocetine has been shown to alter properties of the blood to improve blood flow through the brain. It also improves energy available to the brain by inhibiting phosphodiesterase thus preserving ATP, the source of cell energy.Health Concerns vinpocetine has been featured in over 150 studies. Over thirty quality control tests are conducted for safety and potency. In a study of 203 patients with mild to moderate dementia at the University of Surry, England, subjects were administered vinpocetine at doses of 10 mg TID or 20 mg TID for sixteen weeks. There was a significant cognitive improvement when compared with a placebo. In another double blind trial, vinpocetine produced significant improvement to elderly patients with chronic cerebral dysfunction at dosages of 10 mg TID for 30 days followed by 5 mg TID for 60 days.

description

Therapeutic Actions
1.Improves cerebral circulation
2.May improve memory

patent formula

Vinpurazine

alternative name

Huperzine A

product line

Health Concerns

dosage forms

Capsules

unit size

90 Capsules

dosage

1 or 4 Capsules daily on an empty stomac...

allergy warning

ingredients

Rosemary leaf extract